Connection

Paul Gurbel to Platelet Aggregation Inhibitors

This is a "connection" page, showing publications Paul Gurbel has written about Platelet Aggregation Inhibitors.
Connection Strength

4.283
  1. "Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. J Thromb Thrombolysis. 2019 Feb; 47(2):192-199.
    View in: PubMed
    Score: 0.354
  2. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy? Circulation. 2018 11 06; 138(19):2145-2159.
    View in: PubMed
    Score: 0.349
  3. Cangrelor for the treatment of patients with Arterial Thrombosis. Expert Opin Pharmacother. 2018 Aug; 19(12):1389-1398.
    View in: PubMed
    Score: 0.343
  4. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis. Int J Cardiol. 2018 Oct 15; 269:292-297.
    View in: PubMed
    Score: 0.340
  5. Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention. Thromb Haemost. 2018 Jul; 118(7):1131-1140.
    View in: PubMed
    Score: 0.338
  6. Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments. Expert Opin Pharmacother. 2018 05; 19(7):653-665.
    View in: PubMed
    Score: 0.335
  7. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study. Thromb Haemost. 2018 05; 118(5):864-872.
    View in: PubMed
    Score: 0.335
  8. Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern? Catheter Cardiovasc Interv. 2018 07; 92(1):200-202.
    View in: PubMed
    Score: 0.326
  9. Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May; 51(4):902-904.
    View in: PubMed
    Score: 0.103
  10. Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
    View in: PubMed
    Score: 0.098
  11. Secondary prevention of ischaemic stroke: more evidence to block two pathways affecting platelet activation. Eur Heart J Qual Care Clin Outcomes. 2019 10 01; 5(4):275-278.
    View in: PubMed
    Score: 0.093
  12. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
    View in: PubMed
    Score: 0.087
  13. Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes. Kardiol Pol. 2018; 76(9):1312-1319.
    View in: PubMed
    Score: 0.086
  14. Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial). Am J Cardiol. 2018 10 15; 122(8):1322-1329.
    View in: PubMed
    Score: 0.085
  15. Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study. J Thromb Thrombolysis. 2018 May; 45(4):469-476.
    View in: PubMed
    Score: 0.084
  16. Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium. J Thromb Thrombolysis. 2018 Jan; 45(1):18-26.
    View in: PubMed
    Score: 0.082
  17. Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Curr Vasc Pharmacol. 2018; 16(5):459-476.
    View in: PubMed
    Score: 0.082
  18. International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies. Circulation. 2017 Nov 14; 136(20):1955-1975.
    View in: PubMed
    Score: 0.081
  19. Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother. 2017 10 01; 3(4):221-234.
    View in: PubMed
    Score: 0.081
  20. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
    View in: PubMed
    Score: 0.080
  21. HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm. Eur Heart J. 2017 06 01; 38(21):1687-1689.
    View in: PubMed
    Score: 0.079
  22. ANTARCTIC: platelet function testing to adjust therapy. Lancet. 2017 03 25; 389(10075):1193.
    View in: PubMed
    Score: 0.078
  23. GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes. Lancet. 2017 05 06; 389(10081):1773-1775.
    View in: PubMed
    Score: 0.078
  24. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. Thromb Haemost. 2017 05 03; 117(5):911-922.
    View in: PubMed
    Score: 0.077
  25. Immunity to thrombotic events is achievable if we stop the guessing game: is this the major hidden message from GRAVITAS? Thromb Haemost. 2011 Aug; 106(2):263-4.
    View in: PubMed
    Score: 0.052
  26. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14; 56(12):919-33.
    View in: PubMed
    Score: 0.050
  27. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007 Nov 06; 50(19):1822-34.
    View in: PubMed
    Score: 0.041
  28. Platelet Reactivity and Coagulation Markers in Patients with COVID-19. Adv Ther. 2021 07; 38(7):3911-3923.
    View in: PubMed
    Score: 0.026
  29. Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease. Thromb Haemost. 2019 Feb; 119(2):264-273.
    View in: PubMed
    Score: 0.022
  30. Ticagrelor versus Clopidogrel in Peripheral Artery Disease. N Engl J Med. 2017 04 13; 376(15):1487-8.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.